Concepts (228)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Calcitriol | 4 | 2015 | 7 | 1.790 |
Why?
|
| Vitamin D | 4 | 2015 | 21 | 1.630 |
Why?
|
| Cell Differentiation | 10 | 2015 | 79 | 1.570 |
Why?
|
| Transforming Growth Factor beta | 10 | 2008 | 81 | 1.420 |
Why?
|
| Myocytes, Cardiac | 3 | 2015 | 26 | 1.350 |
Why?
|
| Muscle, Skeletal | 12 | 2011 | 87 | 1.140 |
Why?
|
| Animals | 25 | 2019 | 1238 | 1.040 |
Why?
|
| Muscle Development | 4 | 2012 | 22 | 0.950 |
Why?
|
| Vitamin D Deficiency | 2 | 2011 | 8 | 0.760 |
Why?
|
| Myostatin | 10 | 2011 | 47 | 0.750 |
Why?
|
| Cardiovascular Diseases | 2 | 2011 | 36 | 0.730 |
Why?
|
| Mice | 15 | 2012 | 508 | 0.700 |
Why?
|
| Mesoderm | 3 | 2008 | 9 | 0.660 |
Why?
|
| Muscle Fibers, Skeletal | 3 | 2012 | 22 | 0.560 |
Why?
|
| Heart | 1 | 2015 | 15 | 0.560 |
Why?
|
| Gene Expression | 5 | 2012 | 73 | 0.550 |
Why?
|
| Penis | 5 | 2019 | 110 | 0.540 |
Why?
|
| Cells, Cultured | 9 | 2019 | 164 | 0.530 |
Why?
|
| Cell Proliferation | 3 | 2011 | 110 | 0.520 |
Why?
|
| Fibrosis | 3 | 2011 | 63 | 0.520 |
Why?
|
| Cholecalciferol | 1 | 2014 | 7 | 0.510 |
Why?
|
| Wnt Signaling Pathway | 1 | 2014 | 9 | 0.510 |
Why?
|
| Apoptosis | 4 | 2018 | 162 | 0.490 |
Why?
|
| Neovascularization, Physiologic | 1 | 2012 | 10 | 0.450 |
Why?
|
| Multipotent Stem Cells | 2 | 2010 | 9 | 0.420 |
Why?
|
| Adipocytes | 3 | 2005 | 26 | 0.400 |
Why?
|
| Myoblasts | 2 | 2008 | 12 | 0.390 |
Why?
|
| Phosphodiesterase 5 Inhibitors | 4 | 2019 | 9 | 0.380 |
Why?
|
| Health Status Disparities | 1 | 2011 | 41 | 0.380 |
Why?
|
| Cell Shape | 1 | 2010 | 3 | 0.380 |
Why?
|
| Cell Cycle | 1 | 2010 | 14 | 0.370 |
Why?
|
| Cell Line | 7 | 2012 | 80 | 0.370 |
Why?
|
| Cardiovascular System | 1 | 2009 | 15 | 0.360 |
Why?
|
| Kidney Diseases | 1 | 2009 | 18 | 0.360 |
Why?
|
| Gene Expression Regulation | 6 | 2011 | 93 | 0.350 |
Why?
|
| Receptors, Androgen | 5 | 2008 | 33 | 0.350 |
Why?
|
| Collagen | 1 | 2008 | 26 | 0.340 |
Why?
|
| Piperazines | 3 | 2014 | 24 | 0.330 |
Why?
|
| Myocytes, Smooth Muscle | 2 | 2019 | 28 | 0.330 |
Why?
|
| Fibroblasts | 1 | 2008 | 26 | 0.320 |
Why?
|
| Receptors, Calcitriol | 3 | 2014 | 11 | 0.320 |
Why?
|
| Signal Transduction | 6 | 2012 | 180 | 0.300 |
Why?
|
| Testosterone | 5 | 2005 | 76 | 0.300 |
Why?
|
| RNA, Messenger | 6 | 2012 | 167 | 0.280 |
Why?
|
| Rats | 8 | 2018 | 432 | 0.280 |
Why?
|
| Cell Nucleus | 4 | 2014 | 26 | 0.270 |
Why?
|
| Male | 14 | 2019 | 1649 | 0.270 |
Why?
|
| Humans | 9 | 2015 | 2493 | 0.260 |
Why?
|
| Recombinant Proteins | 5 | 2008 | 33 | 0.260 |
Why?
|
| Follistatin | 3 | 2008 | 18 | 0.250 |
Why?
|
| Reverse Transcriptase Polymerase Chain Reaction | 5 | 2007 | 92 | 0.230 |
Why?
|
| Mice, Inbred C3H | 4 | 2008 | 38 | 0.220 |
Why?
|
| Cyclic GMP | 2 | 2019 | 13 | 0.220 |
Why?
|
| Myosin Heavy Chains | 1 | 2002 | 5 | 0.220 |
Why?
|
| Nitric Oxide | 2 | 2019 | 54 | 0.210 |
Why?
|
| Citrulline | 2 | 2019 | 7 | 0.210 |
Why?
|
| Sulfones | 2 | 2012 | 17 | 0.210 |
Why?
|
| Dietary Supplements | 2 | 2011 | 13 | 0.190 |
Why?
|
| Arginine | 1 | 2019 | 19 | 0.180 |
Why?
|
| RNA, Small Interfering | 3 | 2008 | 32 | 0.180 |
Why?
|
| MyoD Protein | 2 | 2011 | 5 | 0.170 |
Why?
|
| Protein Transport | 3 | 2014 | 16 | 0.170 |
Why?
|
| Transforming Growth Factor beta1 | 2 | 2008 | 24 | 0.170 |
Why?
|
| Ginger | 1 | 2018 | 2 | 0.170 |
Why?
|
| Olacaceae | 1 | 2018 | 2 | 0.170 |
Why?
|
| Paullinia | 1 | 2018 | 2 | 0.170 |
Why?
|
| Time Factors | 2 | 2008 | 120 | 0.160 |
Why?
|
| Glucocorticoids | 3 | 2003 | 39 | 0.160 |
Why?
|
| beta Catenin | 2 | 2008 | 16 | 0.160 |
Why?
|
| Androgens | 2 | 2008 | 29 | 0.140 |
Why?
|
| Blotting, Western | 3 | 2007 | 116 | 0.140 |
Why?
|
| Disease Models, Animal | 3 | 2014 | 143 | 0.140 |
Why?
|
| Immunohistochemistry | 3 | 2005 | 133 | 0.130 |
Why?
|
| Ganglia | 1 | 2014 | 2 | 0.130 |
Why?
|
| Sulfonamides | 1 | 2014 | 10 | 0.130 |
Why?
|
| Embryo, Mammalian | 1 | 2014 | 11 | 0.130 |
Why?
|
| Rats, Sprague-Dawley | 4 | 2019 | 179 | 0.120 |
Why?
|
| Pluripotent Stem Cells | 2 | 2003 | 7 | 0.120 |
Why?
|
| Oxidative Stress | 1 | 2014 | 102 | 0.120 |
Why?
|
| Dexamethasone | 3 | 2003 | 27 | 0.120 |
Why?
|
| Adult | 4 | 2009 | 807 | 0.110 |
Why?
|
| Fibroblast Growth Factor 1 | 1 | 2012 | 2 | 0.110 |
Why?
|
| Tissue Inhibitor of Metalloproteinase-3 | 1 | 2012 | 3 | 0.110 |
Why?
|
| Fibroblast Growth Factor 2 | 1 | 2012 | 5 | 0.110 |
Why?
|
| Up-Regulation | 2 | 2014 | 71 | 0.110 |
Why?
|
| Gene Expression Regulation, Developmental | 1 | 2012 | 21 | 0.110 |
Why?
|
| Vascular Endothelial Growth Factor A | 1 | 2012 | 30 | 0.110 |
Why?
|
| Ganglia, Autonomic | 1 | 2012 | 2 | 0.110 |
Why?
|
| Glial Cell Line-Derived Neurotrophic Factor Receptors | 1 | 2012 | 2 | 0.110 |
Why?
|
| Neuroprotective Agents | 1 | 2012 | 6 | 0.110 |
Why?
|
| Transfection | 3 | 2007 | 46 | 0.110 |
Why?
|
| Organ Size | 3 | 2007 | 33 | 0.110 |
Why?
|
| Growth Differentiation Factors | 1 | 2011 | 2 | 0.100 |
Why?
|
| Active Transport, Cell Nucleus | 1 | 2011 | 4 | 0.100 |
Why?
|
| Bone Morphogenetic Proteins | 1 | 2011 | 6 | 0.100 |
Why?
|
| Insulin-Like Growth Factor II | 1 | 2011 | 7 | 0.100 |
Why?
|
| Intercellular Signaling Peptides and Proteins | 1 | 2011 | 9 | 0.100 |
Why?
|
| Vitamins | 1 | 2011 | 5 | 0.100 |
Why?
|
| Extracellular Matrix | 1 | 2011 | 12 | 0.100 |
Why?
|
| Base Sequence | 3 | 2006 | 65 | 0.100 |
Why?
|
| Genes, cdc | 1 | 2010 | 2 | 0.090 |
Why?
|
| GTP Phosphohydrolases | 1 | 2010 | 2 | 0.090 |
Why?
|
| rhoA GTP-Binding Protein | 1 | 2010 | 2 | 0.090 |
Why?
|
| Oligonucleotide Array Sequence Analysis | 1 | 2010 | 28 | 0.090 |
Why?
|
| Mice, Transgenic | 2 | 2007 | 37 | 0.090 |
Why?
|
| Gene Expression Profiling | 1 | 2010 | 36 | 0.090 |
Why?
|
| TCF Transcription Factors | 2 | 2008 | 6 | 0.090 |
Why?
|
| Nutrition Policy | 1 | 2009 | 1 | 0.090 |
Why?
|
| Hypertrophy, Left Ventricular | 1 | 2009 | 2 | 0.090 |
Why?
|
| United States | 1 | 2011 | 324 | 0.090 |
Why?
|
| Risk Assessment | 1 | 2009 | 55 | 0.090 |
Why?
|
| Chronic Disease | 1 | 2009 | 70 | 0.090 |
Why?
|
| Matrix Metalloproteinase 8 | 1 | 2008 | 1 | 0.090 |
Why?
|
| Nerve Growth Factors | 1 | 2008 | 3 | 0.090 |
Why?
|
| Bone Morphogenetic Protein 7 | 1 | 2008 | 5 | 0.090 |
Why?
|
| Eye Proteins | 1 | 2008 | 3 | 0.090 |
Why?
|
| Serpins | 1 | 2008 | 3 | 0.090 |
Why?
|
| Purines | 3 | 2014 | 15 | 0.090 |
Why?
|
| Risk Factors | 1 | 2009 | 240 | 0.090 |
Why?
|
| Sildenafil Citrate | 3 | 2014 | 17 | 0.080 |
Why?
|
| Ethanol | 1 | 2008 | 52 | 0.080 |
Why?
|
| Smad Proteins | 1 | 2008 | 10 | 0.080 |
Why?
|
| Phenotype | 1 | 2008 | 40 | 0.080 |
Why?
|
| Phosphorylation | 1 | 2008 | 68 | 0.080 |
Why?
|
| Down-Regulation | 1 | 2008 | 52 | 0.080 |
Why?
|
| Video Recording | 1 | 2007 | 4 | 0.080 |
Why?
|
| Mice, Inbred Strains | 1 | 2007 | 14 | 0.080 |
Why?
|
| Heart Ventricles | 1 | 2007 | 12 | 0.080 |
Why?
|
| Stroke Volume | 1 | 2007 | 9 | 0.080 |
Why?
|
| Cell Cycle Proteins | 1 | 2007 | 19 | 0.080 |
Why?
|
| Rats, Inbred F344 | 3 | 2014 | 60 | 0.080 |
Why?
|
| African Americans | 1 | 2011 | 272 | 0.080 |
Why?
|
| Body Composition | 2 | 2003 | 35 | 0.070 |
Why?
|
| Gene Transfer Techniques | 1 | 2006 | 9 | 0.070 |
Why?
|
| Nitric Oxide Synthase Type II | 2 | 2018 | 46 | 0.070 |
Why?
|
| Wnt Proteins | 1 | 2005 | 9 | 0.070 |
Why?
|
| Gestrinone | 1 | 2005 | 1 | 0.070 |
Why?
|
| Transcription Factors | 1 | 2005 | 42 | 0.070 |
Why?
|
| Azacitidine | 1 | 2005 | 4 | 0.070 |
Why?
|
| DNA Primers | 1 | 2005 | 17 | 0.070 |
Why?
|
| Adipose Tissue | 1 | 2005 | 42 | 0.070 |
Why?
|
| Muscle Proteins | 2 | 2003 | 15 | 0.070 |
Why?
|
| Androstenedione | 1 | 2004 | 6 | 0.070 |
Why?
|
| Hypogonadism | 1 | 2004 | 13 | 0.070 |
Why?
|
| Dihydrotestosterone | 1 | 2003 | 9 | 0.060 |
Why?
|
| Muscular Atrophy | 1 | 2003 | 5 | 0.060 |
Why?
|
| Nerve Tissue | 2 | 2014 | 5 | 0.060 |
Why?
|
| Subcellular Fractions | 1 | 2002 | 6 | 0.050 |
Why?
|
| Staining and Labeling | 1 | 2002 | 8 | 0.050 |
Why?
|
| Histocompatibility Antigens Class II | 1 | 2002 | 6 | 0.050 |
Why?
|
| Tissue Distribution | 1 | 2002 | 24 | 0.050 |
Why?
|
| Blotting, Northern | 1 | 2002 | 28 | 0.050 |
Why?
|
| Regulatory Sequences, Nucleic Acid | 1 | 2001 | 7 | 0.050 |
Why?
|
| NG-Nitroarginine Methyl Ester | 1 | 2019 | 9 | 0.040 |
Why?
|
| Nitrites | 1 | 2019 | 5 | 0.040 |
Why?
|
| Cyclic Nucleotide Phosphodiesterases, Type 5 | 1 | 2019 | 8 | 0.040 |
Why?
|
| Muscle, Smooth | 1 | 2019 | 36 | 0.040 |
Why?
|
| Orchiectomy | 2 | 2008 | 11 | 0.040 |
Why?
|
| 3T3 Cells | 2 | 2005 | 16 | 0.030 |
Why?
|
| Heme Oxygenase-1 | 1 | 2014 | 2 | 0.030 |
Why?
|
| NADPH Oxidases | 1 | 2014 | 5 | 0.030 |
Why?
|
| Transcriptome | 1 | 2014 | 18 | 0.030 |
Why?
|
| Penile Erection | 1 | 2014 | 33 | 0.030 |
Why?
|
| Cytokines | 1 | 2014 | 47 | 0.030 |
Why?
|
| Kinetics | 2 | 2004 | 44 | 0.030 |
Why?
|
| Transcription, Genetic | 2 | 2005 | 34 | 0.030 |
Why?
|
| Reference Values | 2 | 2004 | 42 | 0.030 |
Why?
|
| Pelvis | 1 | 2012 | 2 | 0.030 |
Why?
|
| Neurturin | 1 | 2012 | 2 | 0.030 |
Why?
|
| Organ Sparing Treatments | 1 | 2012 | 2 | 0.030 |
Why?
|
| Nitric Oxide Synthase Type I | 1 | 2012 | 30 | 0.030 |
Why?
|
| Cell Division | 2 | 2003 | 39 | 0.030 |
Why?
|
| Adolescent | 2 | 2003 | 305 | 0.030 |
Why?
|
| Neurons | 1 | 2012 | 41 | 0.030 |
Why?
|
| Dose-Response Relationship, Drug | 2 | 2002 | 118 | 0.030 |
Why?
|
| Matrix Metalloproteinase 1 | 1 | 2011 | 2 | 0.030 |
Why?
|
| Transforming Growth Factor beta2 | 1 | 2011 | 2 | 0.030 |
Why?
|
| Epiregulin | 1 | 2011 | 2 | 0.030 |
Why?
|
| Matrix Metalloproteinase 3 | 1 | 2011 | 4 | 0.030 |
Why?
|
| Epidermal Growth Factor | 1 | 2011 | 8 | 0.030 |
Why?
|
| Endothelium, Vascular | 1 | 2011 | 21 | 0.030 |
Why?
|
| Transcription Factor 4 | 1 | 2008 | 4 | 0.020 |
Why?
|
| Receptor Cross-Talk | 1 | 2008 | 4 | 0.020 |
Why?
|
| Basic Helix-Loop-Helix Leucine Zipper Transcription Factors | 1 | 2008 | 7 | 0.020 |
Why?
|
| Nerve Tissue Proteins | 1 | 2008 | 18 | 0.020 |
Why?
|
| Mice, Inbred C57BL | 1 | 2008 | 185 | 0.020 |
Why?
|
| Lac Operon | 1 | 2006 | 4 | 0.020 |
Why?
|
| Gene Silencing | 1 | 2006 | 6 | 0.020 |
Why?
|
| Genes, Reporter | 1 | 2006 | 9 | 0.020 |
Why?
|
| Electroporation | 1 | 2006 | 10 | 0.020 |
Why?
|
| Plasmids | 1 | 2006 | 16 | 0.020 |
Why?
|
| Genetic Vectors | 1 | 2006 | 16 | 0.020 |
Why?
|
| Transcription Factor 7-Like 2 Protein | 1 | 2005 | 2 | 0.020 |
Why?
|
| Ligands | 1 | 2004 | 15 | 0.020 |
Why?
|
| Biopsy, Needle | 1 | 2003 | 12 | 0.020 |
Why?
|
| Sensitivity and Specificity | 1 | 2003 | 45 | 0.020 |
Why?
|
| Child, Preschool | 1 | 2003 | 64 | 0.020 |
Why?
|
| Tosyl Compounds | 1 | 2003 | 3 | 0.020 |
Why?
|
| Nitriles | 1 | 2003 | 6 | 0.010 |
Why?
|
| Anilides | 1 | 2003 | 5 | 0.010 |
Why?
|
| Androgen Antagonists | 1 | 2003 | 6 | 0.010 |
Why?
|
| Stem Cells | 1 | 2003 | 28 | 0.010 |
Why?
|
| Organ Specificity | 1 | 2003 | 8 | 0.010 |
Why?
|
| Child | 1 | 2003 | 126 | 0.010 |
Why?
|
| Mifepristone | 1 | 2003 | 8 | 0.010 |
Why?
|
| Receptors, Glucocorticoid | 1 | 2003 | 23 | 0.010 |
Why?
|
| Body Weight | 1 | 2003 | 65 | 0.010 |
Why?
|
| Sex Factors | 1 | 2003 | 75 | 0.010 |
Why?
|
| Muscle Fibers, Slow-Twitch | 1 | 2002 | 3 | 0.010 |
Why?
|
| Anatomy, Cross-Sectional | 1 | 2002 | 4 | 0.010 |
Why?
|
| Muscle Fibers, Fast-Twitch | 1 | 2002 | 4 | 0.010 |
Why?
|
| Gonadotropin-Releasing Hormone | 1 | 2002 | 16 | 0.010 |
Why?
|
| Hypertrophy | 1 | 2002 | 11 | 0.010 |
Why?
|
| Magnetic Resonance Imaging | 1 | 2002 | 23 | 0.010 |
Why?
|
| Double-Blind Method | 1 | 2002 | 48 | 0.010 |
Why?
|
| Middle Aged | 1 | 2004 | 799 | 0.010 |
Why?
|
| Enhancer Elements, Genetic | 1 | 2001 | 4 | 0.010 |
Why?
|
| DNA Probes | 1 | 2001 | 4 | 0.010 |
Why?
|
| Stimulation, Chemical | 1 | 2001 | 14 | 0.010 |
Why?
|
| Nuclear Proteins | 1 | 2001 | 7 | 0.010 |
Why?
|
| Cloning, Molecular | 1 | 2001 | 16 | 0.010 |
Why?
|
| Molecular Sequence Data | 1 | 2001 | 62 | 0.010 |
Why?
|
| Escherichia coli | 1 | 2001 | 5 | 0.010 |
Why?
|
| Drosophila | 1 | 2001 | 4 | 0.010 |
Why?
|
| CHO Cells | 1 | 2001 | 6 | 0.010 |
Why?
|
| Cricetinae | 1 | 2001 | 11 | 0.010 |
Why?
|
| DNA | 1 | 2001 | 19 | 0.010 |
Why?
|
| Female | 1 | 2003 | 1733 | 0.010 |
Why?
|